Major depressive disorder has emerged among some GLP-1 patients, raising the question of whether rimonabant’s psychiatric harms will recur.

Major depressive disorder has emerged among some GLP-1 patients, raising the question of whether rimonabant’s psychiatric harms will recur.

More from this video

See all →

Don't lose this one

A free account saves insights like this to your Boards, and Korva resurfaces them so you actually remember.